Global Long-acting Insulin Injection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Long-acting Insulin Injection market size was valued at US$ 20710 million in 2024 and is forecast to a readjusted size of USD 22680 million by 2031 with a CAGR of 1.3% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Long-acting insulin injection refers to a type of insulin formulation designed to provide a slow, steady release of insulin over an extended period, typically up to 24 hours or more. It is used as basal insulin therapy to maintain consistent blood glucose levels between meals and overnight in patients with diabetes mellitus. This type of insulin reduces the number of daily injections and minimizes blood sugar fluctuations.
This report is a detailed and comprehensive analysis for global Long-acting Insulin Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Long-acting Insulin Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Long-acting Insulin Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Long-acting Insulin Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Long-acting Insulin Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Long-acting Insulin Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Long-acting Insulin Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Long-acting Insulin Injection, with price, sales quantity, revenue, and global market share of Long-acting Insulin Injection from 2020 to 2025.
Chapter 3, the Long-acting Insulin Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Long-acting Insulin Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Long-acting Insulin Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Long-acting Insulin Injection.
Chapter 14 and 15, to describe Long-acting Insulin Injection sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Long-acting insulin injection refers to a type of insulin formulation designed to provide a slow, steady release of insulin over an extended period, typically up to 24 hours or more. It is used as basal insulin therapy to maintain consistent blood glucose levels between meals and overnight in patients with diabetes mellitus. This type of insulin reduces the number of daily injections and minimizes blood sugar fluctuations.
This report is a detailed and comprehensive analysis for global Long-acting Insulin Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Long-acting Insulin Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Long-acting Insulin Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Long-acting Insulin Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Long-acting Insulin Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Long-acting Insulin Injection
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Long-acting Insulin Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Insulin Degludec
- Insulin Detemir
- Insulin Glargine
- Type 1 Diabetes
- Type 2 Diabetes
- Sanofi
- Eli Lilly & Co
- Biocon Biologics
- Gan & Lee
- Tonghua Dongbao
- Biocare
- United Laboratories
- KALBE PHARMA
- Swixx Biopharma
- INFION PHARMA
- Viatris
- Wockhardt
- Lupin Laboratories
- Cipla
- Novo Nordisk
- Abbott Laboratories
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Long-acting Insulin Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Long-acting Insulin Injection, with price, sales quantity, revenue, and global market share of Long-acting Insulin Injection from 2020 to 2025.
Chapter 3, the Long-acting Insulin Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Long-acting Insulin Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Long-acting Insulin Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Long-acting Insulin Injection.
Chapter 14 and 15, to describe Long-acting Insulin Injection sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Long-acting Insulin Injection Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Insulin Degludec
1.3.3 Insulin Detemir
1.3.4 Insulin Glargine
1.4 Market Analysis by Application
1.4.1 Overview: Global Long-acting Insulin Injection Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Type 1 Diabetes
1.4.3 Type 2 Diabetes
1.5 Global Long-acting Insulin Injection Market Size & Forecast
1.5.1 Global Long-acting Insulin Injection Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Long-acting Insulin Injection Sales Quantity (2020-2031)
1.5.3 Global Long-acting Insulin Injection Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Long-acting Insulin Injection Product and Services
2.1.4 Sanofi Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Sanofi Recent Developments/Updates
2.2 Eli Lilly & Co
2.2.1 Eli Lilly & Co Details
2.2.2 Eli Lilly & Co Major Business
2.2.3 Eli Lilly & Co Long-acting Insulin Injection Product and Services
2.2.4 Eli Lilly & Co Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Eli Lilly & Co Recent Developments/Updates
2.3 Biocon Biologics
2.3.1 Biocon Biologics Details
2.3.2 Biocon Biologics Major Business
2.3.3 Biocon Biologics Long-acting Insulin Injection Product and Services
2.3.4 Biocon Biologics Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Biocon Biologics Recent Developments/Updates
2.4 Gan & Lee
2.4.1 Gan & Lee Details
2.4.2 Gan & Lee Major Business
2.4.3 Gan & Lee Long-acting Insulin Injection Product and Services
2.4.4 Gan & Lee Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Gan & Lee Recent Developments/Updates
2.5 Tonghua Dongbao
2.5.1 Tonghua Dongbao Details
2.5.2 Tonghua Dongbao Major Business
2.5.3 Tonghua Dongbao Long-acting Insulin Injection Product and Services
2.5.4 Tonghua Dongbao Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Tonghua Dongbao Recent Developments/Updates
2.6 Biocare
2.6.1 Biocare Details
2.6.2 Biocare Major Business
2.6.3 Biocare Long-acting Insulin Injection Product and Services
2.6.4 Biocare Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Biocare Recent Developments/Updates
2.7 United Laboratories
2.7.1 United Laboratories Details
2.7.2 United Laboratories Major Business
2.7.3 United Laboratories Long-acting Insulin Injection Product and Services
2.7.4 United Laboratories Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 United Laboratories Recent Developments/Updates
2.8 KALBE PHARMA
2.8.1 KALBE PHARMA Details
2.8.2 KALBE PHARMA Major Business
2.8.3 KALBE PHARMA Long-acting Insulin Injection Product and Services
2.8.4 KALBE PHARMA Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 KALBE PHARMA Recent Developments/Updates
2.9 Swixx Biopharma
2.9.1 Swixx Biopharma Details
2.9.2 Swixx Biopharma Major Business
2.9.3 Swixx Biopharma Long-acting Insulin Injection Product and Services
2.9.4 Swixx Biopharma Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Swixx Biopharma Recent Developments/Updates
2.10 INFION PHARMA
2.10.1 INFION PHARMA Details
2.10.2 INFION PHARMA Major Business
2.10.3 INFION PHARMA Long-acting Insulin Injection Product and Services
2.10.4 INFION PHARMA Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 INFION PHARMA Recent Developments/Updates
2.11 Viatris
2.11.1 Viatris Details
2.11.2 Viatris Major Business
2.11.3 Viatris Long-acting Insulin Injection Product and Services
2.11.4 Viatris Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Viatris Recent Developments/Updates
2.12 Wockhardt
2.12.1 Wockhardt Details
2.12.2 Wockhardt Major Business
2.12.3 Wockhardt Long-acting Insulin Injection Product and Services
2.12.4 Wockhardt Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Wockhardt Recent Developments/Updates
2.13 Lupin Laboratories
2.13.1 Lupin Laboratories Details
2.13.2 Lupin Laboratories Major Business
2.13.3 Lupin Laboratories Long-acting Insulin Injection Product and Services
2.13.4 Lupin Laboratories Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Lupin Laboratories Recent Developments/Updates
2.14 Cipla
2.14.1 Cipla Details
2.14.2 Cipla Major Business
2.14.3 Cipla Long-acting Insulin Injection Product and Services
2.14.4 Cipla Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Cipla Recent Developments/Updates
2.15 Novo Nordisk
2.15.1 Novo Nordisk Details
2.15.2 Novo Nordisk Major Business
2.15.3 Novo Nordisk Long-acting Insulin Injection Product and Services
2.15.4 Novo Nordisk Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Novo Nordisk Recent Developments/Updates
2.16 Abbott Laboratories
2.16.1 Abbott Laboratories Details
2.16.2 Abbott Laboratories Major Business
2.16.3 Abbott Laboratories Long-acting Insulin Injection Product and Services
2.16.4 Abbott Laboratories Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Abbott Laboratories Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: LONG-ACTING INSULIN INJECTION BY MANUFACTURER
3.1 Global Long-acting Insulin Injection Sales Quantity by Manufacturer (2020-2025)
3.2 Global Long-acting Insulin Injection Revenue by Manufacturer (2020-2025)
3.3 Global Long-acting Insulin Injection Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Long-acting Insulin Injection by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Long-acting Insulin Injection Manufacturer Market Share in 2024
3.4.3 Top 6 Long-acting Insulin Injection Manufacturer Market Share in 2024
3.5 Long-acting Insulin Injection Market: Overall Company Footprint Analysis
3.5.1 Long-acting Insulin Injection Market: Region Footprint
3.5.2 Long-acting Insulin Injection Market: Company Product Type Footprint
3.5.3 Long-acting Insulin Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Long-acting Insulin Injection Market Size by Region
4.1.1 Global Long-acting Insulin Injection Sales Quantity by Region (2020-2031)
4.1.2 Global Long-acting Insulin Injection Consumption Value by Region (2020-2031)
4.1.3 Global Long-acting Insulin Injection Average Price by Region (2020-2031)
4.2 North America Long-acting Insulin Injection Consumption Value (2020-2031)
4.3 Europe Long-acting Insulin Injection Consumption Value (2020-2031)
4.4 Asia-Pacific Long-acting Insulin Injection Consumption Value (2020-2031)
4.5 South America Long-acting Insulin Injection Consumption Value (2020-2031)
4.6 Middle East & Africa Long-acting Insulin Injection Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Long-acting Insulin Injection Sales Quantity by Type (2020-2031)
5.2 Global Long-acting Insulin Injection Consumption Value by Type (2020-2031)
5.3 Global Long-acting Insulin Injection Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Long-acting Insulin Injection Sales Quantity by Application (2020-2031)
6.2 Global Long-acting Insulin Injection Consumption Value by Application (2020-2031)
6.3 Global Long-acting Insulin Injection Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Long-acting Insulin Injection Sales Quantity by Type (2020-2031)
7.2 North America Long-acting Insulin Injection Sales Quantity by Application (2020-2031)
7.3 North America Long-acting Insulin Injection Market Size by Country
7.3.1 North America Long-acting Insulin Injection Sales Quantity by Country (2020-2031)
7.3.2 North America Long-acting Insulin Injection Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Long-acting Insulin Injection Sales Quantity by Type (2020-2031)
8.2 Europe Long-acting Insulin Injection Sales Quantity by Application (2020-2031)
8.3 Europe Long-acting Insulin Injection Market Size by Country
8.3.1 Europe Long-acting Insulin Injection Sales Quantity by Country (2020-2031)
8.3.2 Europe Long-acting Insulin Injection Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Long-acting Insulin Injection Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Long-acting Insulin Injection Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Long-acting Insulin Injection Market Size by Region
9.3.1 Asia-Pacific Long-acting Insulin Injection Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Long-acting Insulin Injection Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Long-acting Insulin Injection Sales Quantity by Type (2020-2031)
10.2 South America Long-acting Insulin Injection Sales Quantity by Application (2020-2031)
10.3 South America Long-acting Insulin Injection Market Size by Country
10.3.1 South America Long-acting Insulin Injection Sales Quantity by Country (2020-2031)
10.3.2 South America Long-acting Insulin Injection Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Long-acting Insulin Injection Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Long-acting Insulin Injection Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Long-acting Insulin Injection Market Size by Country
11.3.1 Middle East & Africa Long-acting Insulin Injection Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Long-acting Insulin Injection Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Long-acting Insulin Injection Market Drivers
12.2 Long-acting Insulin Injection Market Restraints
12.3 Long-acting Insulin Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Long-acting Insulin Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Long-acting Insulin Injection
13.3 Long-acting Insulin Injection Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Long-acting Insulin Injection Typical Distributors
14.3 Long-acting Insulin Injection Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Long-acting Insulin Injection Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Insulin Degludec
1.3.3 Insulin Detemir
1.3.4 Insulin Glargine
1.4 Market Analysis by Application
1.4.1 Overview: Global Long-acting Insulin Injection Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Type 1 Diabetes
1.4.3 Type 2 Diabetes
1.5 Global Long-acting Insulin Injection Market Size & Forecast
1.5.1 Global Long-acting Insulin Injection Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Long-acting Insulin Injection Sales Quantity (2020-2031)
1.5.3 Global Long-acting Insulin Injection Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Long-acting Insulin Injection Product and Services
2.1.4 Sanofi Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Sanofi Recent Developments/Updates
2.2 Eli Lilly & Co
2.2.1 Eli Lilly & Co Details
2.2.2 Eli Lilly & Co Major Business
2.2.3 Eli Lilly & Co Long-acting Insulin Injection Product and Services
2.2.4 Eli Lilly & Co Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Eli Lilly & Co Recent Developments/Updates
2.3 Biocon Biologics
2.3.1 Biocon Biologics Details
2.3.2 Biocon Biologics Major Business
2.3.3 Biocon Biologics Long-acting Insulin Injection Product and Services
2.3.4 Biocon Biologics Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Biocon Biologics Recent Developments/Updates
2.4 Gan & Lee
2.4.1 Gan & Lee Details
2.4.2 Gan & Lee Major Business
2.4.3 Gan & Lee Long-acting Insulin Injection Product and Services
2.4.4 Gan & Lee Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Gan & Lee Recent Developments/Updates
2.5 Tonghua Dongbao
2.5.1 Tonghua Dongbao Details
2.5.2 Tonghua Dongbao Major Business
2.5.3 Tonghua Dongbao Long-acting Insulin Injection Product and Services
2.5.4 Tonghua Dongbao Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Tonghua Dongbao Recent Developments/Updates
2.6 Biocare
2.6.1 Biocare Details
2.6.2 Biocare Major Business
2.6.3 Biocare Long-acting Insulin Injection Product and Services
2.6.4 Biocare Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Biocare Recent Developments/Updates
2.7 United Laboratories
2.7.1 United Laboratories Details
2.7.2 United Laboratories Major Business
2.7.3 United Laboratories Long-acting Insulin Injection Product and Services
2.7.4 United Laboratories Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 United Laboratories Recent Developments/Updates
2.8 KALBE PHARMA
2.8.1 KALBE PHARMA Details
2.8.2 KALBE PHARMA Major Business
2.8.3 KALBE PHARMA Long-acting Insulin Injection Product and Services
2.8.4 KALBE PHARMA Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 KALBE PHARMA Recent Developments/Updates
2.9 Swixx Biopharma
2.9.1 Swixx Biopharma Details
2.9.2 Swixx Biopharma Major Business
2.9.3 Swixx Biopharma Long-acting Insulin Injection Product and Services
2.9.4 Swixx Biopharma Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Swixx Biopharma Recent Developments/Updates
2.10 INFION PHARMA
2.10.1 INFION PHARMA Details
2.10.2 INFION PHARMA Major Business
2.10.3 INFION PHARMA Long-acting Insulin Injection Product and Services
2.10.4 INFION PHARMA Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 INFION PHARMA Recent Developments/Updates
2.11 Viatris
2.11.1 Viatris Details
2.11.2 Viatris Major Business
2.11.3 Viatris Long-acting Insulin Injection Product and Services
2.11.4 Viatris Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Viatris Recent Developments/Updates
2.12 Wockhardt
2.12.1 Wockhardt Details
2.12.2 Wockhardt Major Business
2.12.3 Wockhardt Long-acting Insulin Injection Product and Services
2.12.4 Wockhardt Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Wockhardt Recent Developments/Updates
2.13 Lupin Laboratories
2.13.1 Lupin Laboratories Details
2.13.2 Lupin Laboratories Major Business
2.13.3 Lupin Laboratories Long-acting Insulin Injection Product and Services
2.13.4 Lupin Laboratories Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Lupin Laboratories Recent Developments/Updates
2.14 Cipla
2.14.1 Cipla Details
2.14.2 Cipla Major Business
2.14.3 Cipla Long-acting Insulin Injection Product and Services
2.14.4 Cipla Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Cipla Recent Developments/Updates
2.15 Novo Nordisk
2.15.1 Novo Nordisk Details
2.15.2 Novo Nordisk Major Business
2.15.3 Novo Nordisk Long-acting Insulin Injection Product and Services
2.15.4 Novo Nordisk Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Novo Nordisk Recent Developments/Updates
2.16 Abbott Laboratories
2.16.1 Abbott Laboratories Details
2.16.2 Abbott Laboratories Major Business
2.16.3 Abbott Laboratories Long-acting Insulin Injection Product and Services
2.16.4 Abbott Laboratories Long-acting Insulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Abbott Laboratories Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: LONG-ACTING INSULIN INJECTION BY MANUFACTURER
3.1 Global Long-acting Insulin Injection Sales Quantity by Manufacturer (2020-2025)
3.2 Global Long-acting Insulin Injection Revenue by Manufacturer (2020-2025)
3.3 Global Long-acting Insulin Injection Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Long-acting Insulin Injection by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Long-acting Insulin Injection Manufacturer Market Share in 2024
3.4.3 Top 6 Long-acting Insulin Injection Manufacturer Market Share in 2024
3.5 Long-acting Insulin Injection Market: Overall Company Footprint Analysis
3.5.1 Long-acting Insulin Injection Market: Region Footprint
3.5.2 Long-acting Insulin Injection Market: Company Product Type Footprint
3.5.3 Long-acting Insulin Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Long-acting Insulin Injection Market Size by Region
4.1.1 Global Long-acting Insulin Injection Sales Quantity by Region (2020-2031)
4.1.2 Global Long-acting Insulin Injection Consumption Value by Region (2020-2031)
4.1.3 Global Long-acting Insulin Injection Average Price by Region (2020-2031)
4.2 North America Long-acting Insulin Injection Consumption Value (2020-2031)
4.3 Europe Long-acting Insulin Injection Consumption Value (2020-2031)
4.4 Asia-Pacific Long-acting Insulin Injection Consumption Value (2020-2031)
4.5 South America Long-acting Insulin Injection Consumption Value (2020-2031)
4.6 Middle East & Africa Long-acting Insulin Injection Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Long-acting Insulin Injection Sales Quantity by Type (2020-2031)
5.2 Global Long-acting Insulin Injection Consumption Value by Type (2020-2031)
5.3 Global Long-acting Insulin Injection Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Long-acting Insulin Injection Sales Quantity by Application (2020-2031)
6.2 Global Long-acting Insulin Injection Consumption Value by Application (2020-2031)
6.3 Global Long-acting Insulin Injection Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Long-acting Insulin Injection Sales Quantity by Type (2020-2031)
7.2 North America Long-acting Insulin Injection Sales Quantity by Application (2020-2031)
7.3 North America Long-acting Insulin Injection Market Size by Country
7.3.1 North America Long-acting Insulin Injection Sales Quantity by Country (2020-2031)
7.3.2 North America Long-acting Insulin Injection Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Long-acting Insulin Injection Sales Quantity by Type (2020-2031)
8.2 Europe Long-acting Insulin Injection Sales Quantity by Application (2020-2031)
8.3 Europe Long-acting Insulin Injection Market Size by Country
8.3.1 Europe Long-acting Insulin Injection Sales Quantity by Country (2020-2031)
8.3.2 Europe Long-acting Insulin Injection Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Long-acting Insulin Injection Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Long-acting Insulin Injection Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Long-acting Insulin Injection Market Size by Region
9.3.1 Asia-Pacific Long-acting Insulin Injection Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Long-acting Insulin Injection Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Long-acting Insulin Injection Sales Quantity by Type (2020-2031)
10.2 South America Long-acting Insulin Injection Sales Quantity by Application (2020-2031)
10.3 South America Long-acting Insulin Injection Market Size by Country
10.3.1 South America Long-acting Insulin Injection Sales Quantity by Country (2020-2031)
10.3.2 South America Long-acting Insulin Injection Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Long-acting Insulin Injection Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Long-acting Insulin Injection Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Long-acting Insulin Injection Market Size by Country
11.3.1 Middle East & Africa Long-acting Insulin Injection Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Long-acting Insulin Injection Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Long-acting Insulin Injection Market Drivers
12.2 Long-acting Insulin Injection Market Restraints
12.3 Long-acting Insulin Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Long-acting Insulin Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Long-acting Insulin Injection
13.3 Long-acting Insulin Injection Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Long-acting Insulin Injection Typical Distributors
14.3 Long-acting Insulin Injection Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Long-acting Insulin Injection Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Long-acting Insulin Injection Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Long-acting Insulin Injection Product and Services
Table 6. Sanofi Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Sanofi Recent Developments/Updates
Table 8. Eli Lilly & Co Basic Information, Manufacturing Base and Competitors
Table 9. Eli Lilly & Co Major Business
Table 10. Eli Lilly & Co Long-acting Insulin Injection Product and Services
Table 11. Eli Lilly & Co Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Eli Lilly & Co Recent Developments/Updates
Table 13. Biocon Biologics Basic Information, Manufacturing Base and Competitors
Table 14. Biocon Biologics Major Business
Table 15. Biocon Biologics Long-acting Insulin Injection Product and Services
Table 16. Biocon Biologics Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Biocon Biologics Recent Developments/Updates
Table 18. Gan & Lee Basic Information, Manufacturing Base and Competitors
Table 19. Gan & Lee Major Business
Table 20. Gan & Lee Long-acting Insulin Injection Product and Services
Table 21. Gan & Lee Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Gan & Lee Recent Developments/Updates
Table 23. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
Table 24. Tonghua Dongbao Major Business
Table 25. Tonghua Dongbao Long-acting Insulin Injection Product and Services
Table 26. Tonghua Dongbao Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Tonghua Dongbao Recent Developments/Updates
Table 28. Biocare Basic Information, Manufacturing Base and Competitors
Table 29. Biocare Major Business
Table 30. Biocare Long-acting Insulin Injection Product and Services
Table 31. Biocare Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Biocare Recent Developments/Updates
Table 33. United Laboratories Basic Information, Manufacturing Base and Competitors
Table 34. United Laboratories Major Business
Table 35. United Laboratories Long-acting Insulin Injection Product and Services
Table 36. United Laboratories Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. United Laboratories Recent Developments/Updates
Table 38. KALBE PHARMA Basic Information, Manufacturing Base and Competitors
Table 39. KALBE PHARMA Major Business
Table 40. KALBE PHARMA Long-acting Insulin Injection Product and Services
Table 41. KALBE PHARMA Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. KALBE PHARMA Recent Developments/Updates
Table 43. Swixx Biopharma Basic Information, Manufacturing Base and Competitors
Table 44. Swixx Biopharma Major Business
Table 45. Swixx Biopharma Long-acting Insulin Injection Product and Services
Table 46. Swixx Biopharma Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Swixx Biopharma Recent Developments/Updates
Table 48. INFION PHARMA Basic Information, Manufacturing Base and Competitors
Table 49. INFION PHARMA Major Business
Table 50. INFION PHARMA Long-acting Insulin Injection Product and Services
Table 51. INFION PHARMA Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. INFION PHARMA Recent Developments/Updates
Table 53. Viatris Basic Information, Manufacturing Base and Competitors
Table 54. Viatris Major Business
Table 55. Viatris Long-acting Insulin Injection Product and Services
Table 56. Viatris Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Viatris Recent Developments/Updates
Table 58. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 59. Wockhardt Major Business
Table 60. Wockhardt Long-acting Insulin Injection Product and Services
Table 61. Wockhardt Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Wockhardt Recent Developments/Updates
Table 63. Lupin Laboratories Basic Information, Manufacturing Base and Competitors
Table 64. Lupin Laboratories Major Business
Table 65. Lupin Laboratories Long-acting Insulin Injection Product and Services
Table 66. Lupin Laboratories Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Lupin Laboratories Recent Developments/Updates
Table 68. Cipla Basic Information, Manufacturing Base and Competitors
Table 69. Cipla Major Business
Table 70. Cipla Long-acting Insulin Injection Product and Services
Table 71. Cipla Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Cipla Recent Developments/Updates
Table 73. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 74. Novo Nordisk Major Business
Table 75. Novo Nordisk Long-acting Insulin Injection Product and Services
Table 76. Novo Nordisk Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Novo Nordisk Recent Developments/Updates
Table 78. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 79. Abbott Laboratories Major Business
Table 80. Abbott Laboratories Long-acting Insulin Injection Product and Services
Table 81. Abbott Laboratories Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Abbott Laboratories Recent Developments/Updates
Table 83. Global Long-acting Insulin Injection Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 84. Global Long-acting Insulin Injection Revenue by Manufacturer (2020-2025) & (USD Million)
Table 85. Global Long-acting Insulin Injection Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 86. Market Position of Manufacturers in Long-acting Insulin Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 87. Head Office and Long-acting Insulin Injection Production Site of Key Manufacturer
Table 88. Long-acting Insulin Injection Market: Company Product Type Footprint
Table 89. Long-acting Insulin Injection Market: Company Product Application Footprint
Table 90. Long-acting Insulin Injection New Market Entrants and Barriers to Market Entry
Table 91. Long-acting Insulin Injection Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Long-acting Insulin Injection Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 93. Global Long-acting Insulin Injection Sales Quantity by Region (2020-2025) & (K Units)
Table 94. Global Long-acting Insulin Injection Sales Quantity by Region (2026-2031) & (K Units)
Table 95. Global Long-acting Insulin Injection Consumption Value by Region (2020-2025) & (USD Million)
Table 96. Global Long-acting Insulin Injection Consumption Value by Region (2026-2031) & (USD Million)
Table 97. Global Long-acting Insulin Injection Average Price by Region (2020-2025) & (US$/Unit)
Table 98. Global Long-acting Insulin Injection Average Price by Region (2026-2031) & (US$/Unit)
Table 99. Global Long-acting Insulin Injection Sales Quantity by Type (2020-2025) & (K Units)
Table 100. Global Long-acting Insulin Injection Sales Quantity by Type (2026-2031) & (K Units)
Table 101. Global Long-acting Insulin Injection Consumption Value by Type (2020-2025) & (USD Million)
Table 102. Global Long-acting Insulin Injection Consumption Value by Type (2026-2031) & (USD Million)
Table 103. Global Long-acting Insulin Injection Average Price by Type (2020-2025) & (US$/Unit)
Table 104. Global Long-acting Insulin Injection Average Price by Type (2026-2031) & (US$/Unit)
Table 105. Global Long-acting Insulin Injection Sales Quantity by Application (2020-2025) & (K Units)
Table 106. Global Long-acting Insulin Injection Sales Quantity by Application (2026-2031) & (K Units)
Table 107. Global Long-acting Insulin Injection Consumption Value by Application (2020-2025) & (USD Million)
Table 108. Global Long-acting Insulin Injection Consumption Value by Application (2026-2031) & (USD Million)
Table 109. Global Long-acting Insulin Injection Average Price by Application (2020-2025) & (US$/Unit)
Table 110. Global Long-acting Insulin Injection Average Price by Application (2026-2031) & (US$/Unit)
Table 111. North America Long-acting Insulin Injection Sales Quantity by Type (2020-2025) & (K Units)
Table 112. North America Long-acting Insulin Injection Sales Quantity by Type (2026-2031) & (K Units)
Table 113. North America Long-acting Insulin Injection Sales Quantity by Application (2020-2025) & (K Units)
Table 114. North America Long-acting Insulin Injection Sales Quantity by Application (2026-2031) & (K Units)
Table 115. North America Long-acting Insulin Injection Sales Quantity by Country (2020-2025) & (K Units)
Table 116. North America Long-acting Insulin Injection Sales Quantity by Country (2026-2031) & (K Units)
Table 117. North America Long-acting Insulin Injection Consumption Value by Country (2020-2025) & (USD Million)
Table 118. North America Long-acting Insulin Injection Consumption Value by Country (2026-2031) & (USD Million)
Table 119. Europe Long-acting Insulin Injection Sales Quantity by Type (2020-2025) & (K Units)
Table 120. Europe Long-acting Insulin Injection Sales Quantity by Type (2026-2031) & (K Units)
Table 121. Europe Long-acting Insulin Injection Sales Quantity by Application (2020-2025) & (K Units)
Table 122. Europe Long-acting Insulin Injection Sales Quantity by Application (2026-2031) & (K Units)
Table 123. Europe Long-acting Insulin Injection Sales Quantity by Country (2020-2025) & (K Units)
Table 124. Europe Long-acting Insulin Injection Sales Quantity by Country (2026-2031) & (K Units)
Table 125. Europe Long-acting Insulin Injection Consumption Value by Country (2020-2025) & (USD Million)
Table 126. Europe Long-acting Insulin Injection Consumption Value by Country (2026-2031) & (USD Million)
Table 127. Asia-Pacific Long-acting Insulin Injection Sales Quantity by Type (2020-2025) & (K Units)
Table 128. Asia-Pacific Long-acting Insulin Injection Sales Quantity by Type (2026-2031) & (K Units)
Table 129. Asia-Pacific Long-acting Insulin Injection Sales Quantity by Application (2020-2025) & (K Units)
Table 130. Asia-Pacific Long-acting Insulin Injection Sales Quantity by Application (2026-2031) & (K Units)
Table 131. Asia-Pacific Long-acting Insulin Injection Sales Quantity by Region (2020-2025) & (K Units)
Table 132. Asia-Pacific Long-acting Insulin Injection Sales Quantity by Region (2026-2031) & (K Units)
Table 133. Asia-Pacific Long-acting Insulin Injection Consumption Value by Region (2020-2025) & (USD Million)
Table 134. Asia-Pacific Long-acting Insulin Injection Consumption Value by Region (2026-2031) & (USD Million)
Table 135. South America Long-acting Insulin Injection Sales Quantity by Type (2020-2025) & (K Units)
Table 136. South America Long-acting Insulin Injection Sales Quantity by Type (2026-2031) & (K Units)
Table 137. South America Long-acting Insulin Injection Sales Quantity by Application (2020-2025) & (K Units)
Table 138. South America Long-acting Insulin Injection Sales Quantity by Application (2026-2031) & (K Units)
Table 139. South America Long-acting Insulin Injection Sales Quantity by Country (2020-2025) & (K Units)
Table 140. South America Long-acting Insulin Injection Sales Quantity by Country (2026-2031) & (K Units)
Table 141. South America Long-acting Insulin Injection Consumption Value by Country (2020-2025) & (USD Million)
Table 142. South America Long-acting Insulin Injection Consumption Value by Country (2026-2031) & (USD Million)
Table 143. Middle East & Africa Long-acting Insulin Injection Sales Quantity by Type (2020-2025) & (K Units)
Table 144. Middle East & Africa Long-acting Insulin Injection Sales Quantity by Type (2026-2031) & (K Units)
Table 145. Middle East & Africa Long-acting Insulin Injection Sales Quantity by Application (2020-2025) & (K Units)
Table 146. Middle East & Africa Long-acting Insulin Injection Sales Quantity by Application (2026-2031) & (K Units)
Table 147. Middle East & Africa Long-acting Insulin Injection Sales Quantity by Country (2020-2025) & (K Units)
Table 148. Middle East & Africa Long-acting Insulin Injection Sales Quantity by Country (2026-2031) & (K Units)
Table 149. Middle East & Africa Long-acting Insulin Injection Consumption Value by Country (2020-2025) & (USD Million)
Table 150. Middle East & Africa Long-acting Insulin Injection Consumption Value by Country (2026-2031) & (USD Million)
Table 151. Long-acting Insulin Injection Raw Material
Table 152. Key Manufacturers of Long-acting Insulin Injection Raw Materials
Table 153. Long-acting Insulin Injection Typical Distributors
Table 154. Long-acting Insulin Injection Typical Customers
Table 1. Global Long-acting Insulin Injection Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Long-acting Insulin Injection Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Long-acting Insulin Injection Product and Services
Table 6. Sanofi Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Sanofi Recent Developments/Updates
Table 8. Eli Lilly & Co Basic Information, Manufacturing Base and Competitors
Table 9. Eli Lilly & Co Major Business
Table 10. Eli Lilly & Co Long-acting Insulin Injection Product and Services
Table 11. Eli Lilly & Co Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Eli Lilly & Co Recent Developments/Updates
Table 13. Biocon Biologics Basic Information, Manufacturing Base and Competitors
Table 14. Biocon Biologics Major Business
Table 15. Biocon Biologics Long-acting Insulin Injection Product and Services
Table 16. Biocon Biologics Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Biocon Biologics Recent Developments/Updates
Table 18. Gan & Lee Basic Information, Manufacturing Base and Competitors
Table 19. Gan & Lee Major Business
Table 20. Gan & Lee Long-acting Insulin Injection Product and Services
Table 21. Gan & Lee Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Gan & Lee Recent Developments/Updates
Table 23. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
Table 24. Tonghua Dongbao Major Business
Table 25. Tonghua Dongbao Long-acting Insulin Injection Product and Services
Table 26. Tonghua Dongbao Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Tonghua Dongbao Recent Developments/Updates
Table 28. Biocare Basic Information, Manufacturing Base and Competitors
Table 29. Biocare Major Business
Table 30. Biocare Long-acting Insulin Injection Product and Services
Table 31. Biocare Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Biocare Recent Developments/Updates
Table 33. United Laboratories Basic Information, Manufacturing Base and Competitors
Table 34. United Laboratories Major Business
Table 35. United Laboratories Long-acting Insulin Injection Product and Services
Table 36. United Laboratories Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. United Laboratories Recent Developments/Updates
Table 38. KALBE PHARMA Basic Information, Manufacturing Base and Competitors
Table 39. KALBE PHARMA Major Business
Table 40. KALBE PHARMA Long-acting Insulin Injection Product and Services
Table 41. KALBE PHARMA Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. KALBE PHARMA Recent Developments/Updates
Table 43. Swixx Biopharma Basic Information, Manufacturing Base and Competitors
Table 44. Swixx Biopharma Major Business
Table 45. Swixx Biopharma Long-acting Insulin Injection Product and Services
Table 46. Swixx Biopharma Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Swixx Biopharma Recent Developments/Updates
Table 48. INFION PHARMA Basic Information, Manufacturing Base and Competitors
Table 49. INFION PHARMA Major Business
Table 50. INFION PHARMA Long-acting Insulin Injection Product and Services
Table 51. INFION PHARMA Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. INFION PHARMA Recent Developments/Updates
Table 53. Viatris Basic Information, Manufacturing Base and Competitors
Table 54. Viatris Major Business
Table 55. Viatris Long-acting Insulin Injection Product and Services
Table 56. Viatris Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Viatris Recent Developments/Updates
Table 58. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 59. Wockhardt Major Business
Table 60. Wockhardt Long-acting Insulin Injection Product and Services
Table 61. Wockhardt Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Wockhardt Recent Developments/Updates
Table 63. Lupin Laboratories Basic Information, Manufacturing Base and Competitors
Table 64. Lupin Laboratories Major Business
Table 65. Lupin Laboratories Long-acting Insulin Injection Product and Services
Table 66. Lupin Laboratories Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Lupin Laboratories Recent Developments/Updates
Table 68. Cipla Basic Information, Manufacturing Base and Competitors
Table 69. Cipla Major Business
Table 70. Cipla Long-acting Insulin Injection Product and Services
Table 71. Cipla Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Cipla Recent Developments/Updates
Table 73. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 74. Novo Nordisk Major Business
Table 75. Novo Nordisk Long-acting Insulin Injection Product and Services
Table 76. Novo Nordisk Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Novo Nordisk Recent Developments/Updates
Table 78. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 79. Abbott Laboratories Major Business
Table 80. Abbott Laboratories Long-acting Insulin Injection Product and Services
Table 81. Abbott Laboratories Long-acting Insulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Abbott Laboratories Recent Developments/Updates
Table 83. Global Long-acting Insulin Injection Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 84. Global Long-acting Insulin Injection Revenue by Manufacturer (2020-2025) & (USD Million)
Table 85. Global Long-acting Insulin Injection Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 86. Market Position of Manufacturers in Long-acting Insulin Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 87. Head Office and Long-acting Insulin Injection Production Site of Key Manufacturer
Table 88. Long-acting Insulin Injection Market: Company Product Type Footprint
Table 89. Long-acting Insulin Injection Market: Company Product Application Footprint
Table 90. Long-acting Insulin Injection New Market Entrants and Barriers to Market Entry
Table 91. Long-acting Insulin Injection Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Long-acting Insulin Injection Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 93. Global Long-acting Insulin Injection Sales Quantity by Region (2020-2025) & (K Units)
Table 94. Global Long-acting Insulin Injection Sales Quantity by Region (2026-2031) & (K Units)
Table 95. Global Long-acting Insulin Injection Consumption Value by Region (2020-2025) & (USD Million)
Table 96. Global Long-acting Insulin Injection Consumption Value by Region (2026-2031) & (USD Million)
Table 97. Global Long-acting Insulin Injection Average Price by Region (2020-2025) & (US$/Unit)
Table 98. Global Long-acting Insulin Injection Average Price by Region (2026-2031) & (US$/Unit)
Table 99. Global Long-acting Insulin Injection Sales Quantity by Type (2020-2025) & (K Units)
Table 100. Global Long-acting Insulin Injection Sales Quantity by Type (2026-2031) & (K Units)
Table 101. Global Long-acting Insulin Injection Consumption Value by Type (2020-2025) & (USD Million)
Table 102. Global Long-acting Insulin Injection Consumption Value by Type (2026-2031) & (USD Million)
Table 103. Global Long-acting Insulin Injection Average Price by Type (2020-2025) & (US$/Unit)
Table 104. Global Long-acting Insulin Injection Average Price by Type (2026-2031) & (US$/Unit)
Table 105. Global Long-acting Insulin Injection Sales Quantity by Application (2020-2025) & (K Units)
Table 106. Global Long-acting Insulin Injection Sales Quantity by Application (2026-2031) & (K Units)
Table 107. Global Long-acting Insulin Injection Consumption Value by Application (2020-2025) & (USD Million)
Table 108. Global Long-acting Insulin Injection Consumption Value by Application (2026-2031) & (USD Million)
Table 109. Global Long-acting Insulin Injection Average Price by Application (2020-2025) & (US$/Unit)
Table 110. Global Long-acting Insulin Injection Average Price by Application (2026-2031) & (US$/Unit)
Table 111. North America Long-acting Insulin Injection Sales Quantity by Type (2020-2025) & (K Units)
Table 112. North America Long-acting Insulin Injection Sales Quantity by Type (2026-2031) & (K Units)
Table 113. North America Long-acting Insulin Injection Sales Quantity by Application (2020-2025) & (K Units)
Table 114. North America Long-acting Insulin Injection Sales Quantity by Application (2026-2031) & (K Units)
Table 115. North America Long-acting Insulin Injection Sales Quantity by Country (2020-2025) & (K Units)
Table 116. North America Long-acting Insulin Injection Sales Quantity by Country (2026-2031) & (K Units)
Table 117. North America Long-acting Insulin Injection Consumption Value by Country (2020-2025) & (USD Million)
Table 118. North America Long-acting Insulin Injection Consumption Value by Country (2026-2031) & (USD Million)
Table 119. Europe Long-acting Insulin Injection Sales Quantity by Type (2020-2025) & (K Units)
Table 120. Europe Long-acting Insulin Injection Sales Quantity by Type (2026-2031) & (K Units)
Table 121. Europe Long-acting Insulin Injection Sales Quantity by Application (2020-2025) & (K Units)
Table 122. Europe Long-acting Insulin Injection Sales Quantity by Application (2026-2031) & (K Units)
Table 123. Europe Long-acting Insulin Injection Sales Quantity by Country (2020-2025) & (K Units)
Table 124. Europe Long-acting Insulin Injection Sales Quantity by Country (2026-2031) & (K Units)
Table 125. Europe Long-acting Insulin Injection Consumption Value by Country (2020-2025) & (USD Million)
Table 126. Europe Long-acting Insulin Injection Consumption Value by Country (2026-2031) & (USD Million)
Table 127. Asia-Pacific Long-acting Insulin Injection Sales Quantity by Type (2020-2025) & (K Units)
Table 128. Asia-Pacific Long-acting Insulin Injection Sales Quantity by Type (2026-2031) & (K Units)
Table 129. Asia-Pacific Long-acting Insulin Injection Sales Quantity by Application (2020-2025) & (K Units)
Table 130. Asia-Pacific Long-acting Insulin Injection Sales Quantity by Application (2026-2031) & (K Units)
Table 131. Asia-Pacific Long-acting Insulin Injection Sales Quantity by Region (2020-2025) & (K Units)
Table 132. Asia-Pacific Long-acting Insulin Injection Sales Quantity by Region (2026-2031) & (K Units)
Table 133. Asia-Pacific Long-acting Insulin Injection Consumption Value by Region (2020-2025) & (USD Million)
Table 134. Asia-Pacific Long-acting Insulin Injection Consumption Value by Region (2026-2031) & (USD Million)
Table 135. South America Long-acting Insulin Injection Sales Quantity by Type (2020-2025) & (K Units)
Table 136. South America Long-acting Insulin Injection Sales Quantity by Type (2026-2031) & (K Units)
Table 137. South America Long-acting Insulin Injection Sales Quantity by Application (2020-2025) & (K Units)
Table 138. South America Long-acting Insulin Injection Sales Quantity by Application (2026-2031) & (K Units)
Table 139. South America Long-acting Insulin Injection Sales Quantity by Country (2020-2025) & (K Units)
Table 140. South America Long-acting Insulin Injection Sales Quantity by Country (2026-2031) & (K Units)
Table 141. South America Long-acting Insulin Injection Consumption Value by Country (2020-2025) & (USD Million)
Table 142. South America Long-acting Insulin Injection Consumption Value by Country (2026-2031) & (USD Million)
Table 143. Middle East & Africa Long-acting Insulin Injection Sales Quantity by Type (2020-2025) & (K Units)
Table 144. Middle East & Africa Long-acting Insulin Injection Sales Quantity by Type (2026-2031) & (K Units)
Table 145. Middle East & Africa Long-acting Insulin Injection Sales Quantity by Application (2020-2025) & (K Units)
Table 146. Middle East & Africa Long-acting Insulin Injection Sales Quantity by Application (2026-2031) & (K Units)
Table 147. Middle East & Africa Long-acting Insulin Injection Sales Quantity by Country (2020-2025) & (K Units)
Table 148. Middle East & Africa Long-acting Insulin Injection Sales Quantity by Country (2026-2031) & (K Units)
Table 149. Middle East & Africa Long-acting Insulin Injection Consumption Value by Country (2020-2025) & (USD Million)
Table 150. Middle East & Africa Long-acting Insulin Injection Consumption Value by Country (2026-2031) & (USD Million)
Table 151. Long-acting Insulin Injection Raw Material
Table 152. Key Manufacturers of Long-acting Insulin Injection Raw Materials
Table 153. Long-acting Insulin Injection Typical Distributors
Table 154. Long-acting Insulin Injection Typical Customers
LIST OF FIGURES
Figure 1. Long-acting Insulin Injection Picture
Figure 2. Global Long-acting Insulin Injection Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Long-acting Insulin Injection Revenue Market Share by Type in 2024
Figure 4. Insulin Degludec Examples
Figure 5. Insulin Detemir Examples
Figure 6. Insulin Glargine Examples
Figure 7. Global Long-acting Insulin Injection Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global Long-acting Insulin Injection Revenue Market Share by Application in 2024
Figure 9. Type 1 Diabetes Examples
Figure 10. Type 2 Diabetes Examples
Figure 11. Global Long-acting Insulin Injection Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Long-acting Insulin Injection Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Long-acting Insulin Injection Sales Quantity (2020-2031) & (K Units)
Figure 14. Global Long-acting Insulin Injection Price (2020-2031) & (US$/Unit)
Figure 15. Global Long-acting Insulin Injection Sales Quantity Market Share by Manufacturer in 2024
Figure 16. Global Long-acting Insulin Injection Revenue Market Share by Manufacturer in 2024
Figure 17. Producer Shipments of Long-acting Insulin Injection by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 18. Top 3 Long-acting Insulin Injection Manufacturer (Revenue) Market Share in 2024
Figure 19. Top 6 Long-acting Insulin Injection Manufacturer (Revenue) Market Share in 2024
Figure 20. Global Long-acting Insulin Injection Sales Quantity Market Share by Region (2020-2031)
Figure 21. Global Long-acting Insulin Injection Consumption Value Market Share by Region (2020-2031)
Figure 22. North America Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 23. Europe Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 24. Asia-Pacific Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 25. South America Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 26. Middle East & Africa Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 27. Global Long-acting Insulin Injection Sales Quantity Market Share by Type (2020-2031)
Figure 28. Global Long-acting Insulin Injection Consumption Value Market Share by Type (2020-2031)
Figure 29. Global Long-acting Insulin Injection Average Price by Type (2020-2031) & (US$/Unit)
Figure 30. Global Long-acting Insulin Injection Sales Quantity Market Share by Application (2020-2031)
Figure 31. Global Long-acting Insulin Injection Revenue Market Share by Application (2020-2031)
Figure 32. Global Long-acting Insulin Injection Average Price by Application (2020-2031) & (US$/Unit)
Figure 33. North America Long-acting Insulin Injection Sales Quantity Market Share by Type (2020-2031)
Figure 34. North America Long-acting Insulin Injection Sales Quantity Market Share by Application (2020-2031)
Figure 35. North America Long-acting Insulin Injection Sales Quantity Market Share by Country (2020-2031)
Figure 36. North America Long-acting Insulin Injection Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Long-acting Insulin Injection Sales Quantity Market Share by Type (2020-2031)
Figure 41. Europe Long-acting Insulin Injection Sales Quantity Market Share by Application (2020-2031)
Figure 42. Europe Long-acting Insulin Injection Sales Quantity Market Share by Country (2020-2031)
Figure 43. Europe Long-acting Insulin Injection Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 45. France Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Long-acting Insulin Injection Sales Quantity Market Share by Type (2020-2031)
Figure 50. Asia-Pacific Long-acting Insulin Injection Sales Quantity Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Long-acting Insulin Injection Sales Quantity Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Long-acting Insulin Injection Consumption Value Market Share by Region (2020-2031)
Figure 53. China Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 54. Japan Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 55. South Korea Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 56. India Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 57. Southeast Asia Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 58. Australia Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 59. South America Long-acting Insulin Injection Sales Quantity Market Share by Type (2020-2031)
Figure 60. South America Long-acting Insulin Injection Sales Quantity Market Share by Application (2020-2031)
Figure 61. South America Long-acting Insulin Injection Sales Quantity Market Share by Country (2020-2031)
Figure 62. South America Long-acting Insulin Injection Consumption Value Market Share by Country (2020-2031)
Figure 63. Brazil Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 64. Argentina Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 65. Middle East & Africa Long-acting Insulin Injection Sales Quantity Market Share by Type (2020-2031)
Figure 66. Middle East & Africa Long-acting Insulin Injection Sales Quantity Market Share by Application (2020-2031)
Figure 67. Middle East & Africa Long-acting Insulin Injection Sales Quantity Market Share by Country (2020-2031)
Figure 68. Middle East & Africa Long-acting Insulin Injection Consumption Value Market Share by Country (2020-2031)
Figure 69. Turkey Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 70. Egypt Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 71. Saudi Arabia Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 72. South Africa Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 73. Long-acting Insulin Injection Market Drivers
Figure 74. Long-acting Insulin Injection Market Restraints
Figure 75. Long-acting Insulin Injection Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Long-acting Insulin Injection in 2024
Figure 78. Manufacturing Process Analysis of Long-acting Insulin Injection
Figure 79. Long-acting Insulin Injection Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Long-acting Insulin Injection Picture
Figure 2. Global Long-acting Insulin Injection Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Long-acting Insulin Injection Revenue Market Share by Type in 2024
Figure 4. Insulin Degludec Examples
Figure 5. Insulin Detemir Examples
Figure 6. Insulin Glargine Examples
Figure 7. Global Long-acting Insulin Injection Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global Long-acting Insulin Injection Revenue Market Share by Application in 2024
Figure 9. Type 1 Diabetes Examples
Figure 10. Type 2 Diabetes Examples
Figure 11. Global Long-acting Insulin Injection Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Long-acting Insulin Injection Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Long-acting Insulin Injection Sales Quantity (2020-2031) & (K Units)
Figure 14. Global Long-acting Insulin Injection Price (2020-2031) & (US$/Unit)
Figure 15. Global Long-acting Insulin Injection Sales Quantity Market Share by Manufacturer in 2024
Figure 16. Global Long-acting Insulin Injection Revenue Market Share by Manufacturer in 2024
Figure 17. Producer Shipments of Long-acting Insulin Injection by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 18. Top 3 Long-acting Insulin Injection Manufacturer (Revenue) Market Share in 2024
Figure 19. Top 6 Long-acting Insulin Injection Manufacturer (Revenue) Market Share in 2024
Figure 20. Global Long-acting Insulin Injection Sales Quantity Market Share by Region (2020-2031)
Figure 21. Global Long-acting Insulin Injection Consumption Value Market Share by Region (2020-2031)
Figure 22. North America Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 23. Europe Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 24. Asia-Pacific Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 25. South America Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 26. Middle East & Africa Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 27. Global Long-acting Insulin Injection Sales Quantity Market Share by Type (2020-2031)
Figure 28. Global Long-acting Insulin Injection Consumption Value Market Share by Type (2020-2031)
Figure 29. Global Long-acting Insulin Injection Average Price by Type (2020-2031) & (US$/Unit)
Figure 30. Global Long-acting Insulin Injection Sales Quantity Market Share by Application (2020-2031)
Figure 31. Global Long-acting Insulin Injection Revenue Market Share by Application (2020-2031)
Figure 32. Global Long-acting Insulin Injection Average Price by Application (2020-2031) & (US$/Unit)
Figure 33. North America Long-acting Insulin Injection Sales Quantity Market Share by Type (2020-2031)
Figure 34. North America Long-acting Insulin Injection Sales Quantity Market Share by Application (2020-2031)
Figure 35. North America Long-acting Insulin Injection Sales Quantity Market Share by Country (2020-2031)
Figure 36. North America Long-acting Insulin Injection Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Long-acting Insulin Injection Sales Quantity Market Share by Type (2020-2031)
Figure 41. Europe Long-acting Insulin Injection Sales Quantity Market Share by Application (2020-2031)
Figure 42. Europe Long-acting Insulin Injection Sales Quantity Market Share by Country (2020-2031)
Figure 43. Europe Long-acting Insulin Injection Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 45. France Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Long-acting Insulin Injection Sales Quantity Market Share by Type (2020-2031)
Figure 50. Asia-Pacific Long-acting Insulin Injection Sales Quantity Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Long-acting Insulin Injection Sales Quantity Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Long-acting Insulin Injection Consumption Value Market Share by Region (2020-2031)
Figure 53. China Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 54. Japan Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 55. South Korea Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 56. India Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 57. Southeast Asia Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 58. Australia Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 59. South America Long-acting Insulin Injection Sales Quantity Market Share by Type (2020-2031)
Figure 60. South America Long-acting Insulin Injection Sales Quantity Market Share by Application (2020-2031)
Figure 61. South America Long-acting Insulin Injection Sales Quantity Market Share by Country (2020-2031)
Figure 62. South America Long-acting Insulin Injection Consumption Value Market Share by Country (2020-2031)
Figure 63. Brazil Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 64. Argentina Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 65. Middle East & Africa Long-acting Insulin Injection Sales Quantity Market Share by Type (2020-2031)
Figure 66. Middle East & Africa Long-acting Insulin Injection Sales Quantity Market Share by Application (2020-2031)
Figure 67. Middle East & Africa Long-acting Insulin Injection Sales Quantity Market Share by Country (2020-2031)
Figure 68. Middle East & Africa Long-acting Insulin Injection Consumption Value Market Share by Country (2020-2031)
Figure 69. Turkey Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 70. Egypt Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 71. Saudi Arabia Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 72. South Africa Long-acting Insulin Injection Consumption Value (2020-2031) & (USD Million)
Figure 73. Long-acting Insulin Injection Market Drivers
Figure 74. Long-acting Insulin Injection Market Restraints
Figure 75. Long-acting Insulin Injection Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Long-acting Insulin Injection in 2024
Figure 78. Manufacturing Process Analysis of Long-acting Insulin Injection
Figure 79. Long-acting Insulin Injection Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
